Location: New York, NY
CIK: 0001855655 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $750M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | GLOBAL BLOOD THERAPEUTICS IN | 1,175,879 | $80.08M | 10.7% | $30.85 | — | COM | 37890U108 |
| — | MIRATI THERAPEUTICS INC | 850,385 | $59.39M | 7.9% | $76.94 | — | COM | 60468T105 |
| INCY | INCYTE CORP | 773,082 | $51.52M | 6.9% | $74.39 | -0.7% | COM | 45337C102 |
| ASND | ASCENDIS PHARMA A/S | 497,347 | $51.36M | 6.8% | $117.62 | — | SPONSORED ADR | 04351P101 |
| LEGN | LEGEND BIOTECH CORP | 1,076,591 | $43.92M | 5.9% | $42.97 | — | SPONSORED ADS | 52490G102 |
| BIIB | BIOGEN INC | 154,605 | $41.28M | 5.5% | $212.38 | 0.0% | COM | 09062X103 |
| BIIB | BIOGEN INC | 150,000 | $40.05M | 5.3% | $212.38 | 0.0% | Call | 09062X103 |
| IMCR | IMMUNOCORE HLDGS PLC | 773,079 | $36.29M | 4.8% | $34.60 | — | ADS | 45258D105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,636,211 | $33.56M | 4.5% | $18.35 | -2.0% | COM | 92790C104 |
| ARGX | ARGENX SE | 90,297 | $31.88M | 4.2% | $378.46 | — | SPONSORED ADR | 04016X101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 140,561 | $29.43M | 3.9% | $197.37 | +13.3% | COM | 91307C102 |
| — | AKERO THERAPEUTICS INC | 833,265 | $28.37M | 3.8% | $34.05 | — | COM | 00973Y108 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,158,686 | $26.95M | 3.6% | $17.40 | — | SPONSORED ADS | 088786108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,085,142 | $26.08M | 3.5% | $18.57 | +20.8% | COM | 87164F105 |
| AXSM | AXSOME THERAPEUTICS INC | 520,080 | $23.21M | 3.1% | $49.97 | 0.0% | COM | 05464T104 |
| — | HORIZON THERAPEUTICS PUB L | 351,405 | $21.75M | 2.9% | $61.89 | — | SHS | G46188101 |
| — | ALPINE IMMUNE SCIENCES INC | 2,214,722 | $15.95M | 2.1% | $7.76 | — | COM | 02083G100 |
| PRTA | PROTHENA CORP PLC | 235,826 | $14.3M | 1.9% | $31.61 | 0.0% | SHS | G72800108 |
| ARVN | ARVINAS INC | 283,777 | $12.63M | 1.7% | $74.11 | -34.5% | COM | 04335A105 |
| ESPR | ESPERION THERAPEUTICS INC NE | 1,719,831 | $11.52M | 1.5% | $6.77 | +1.4% | COM | 29664W105 |
| — | MERUS N V | 564,214 | $11.3M | 1.5% | $23.80 | — | COM | N5749R100 |
| — | G1 THERAPEUTICS INC | 884,574 | $11.05M | 1.5% | $12.49 | — | COM | 3621LQ109 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 519,256 | $10.2M | 1.4% | $20.39 | 0.0% | COM | 22663K107 |
| — | OYSTER PT PHARMA INC | 1,648,316 | $9.264M | 1.2% | $10.18 | — | COM | 69242L106 |
| TGTX | TG THERAPEUTICS INC | 1,505,479 | $8.912M | 1.2% | $6.24 | +5.0% | COM | 88322Q108 |
| — | POSEIDA THERAPEUTICS INC | 2,070,108 | $7.307M | 1.0% | $3.53 | — | COM | 73730P108 |
| — | VOR BIOPHARMA INC | 1,703,645 | $6.781M | 0.9% | $7.36 | — | COM | 929033108 |
| MIST | MILESTONE PHARMACEUTICALS IN | 634,211 | $5.828M | 0.8% | $7.58 | 0.0% | COM | 59935V107 |